Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 1

Status

Active not recruiting 4Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Hypoxia 2Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
fluoroazomycin arabinoside × 1 year × Clear all
NCT01549730 2026-04-29

Cervix Hypoxia FAZA

University Health Network, Toronto

Phase NA Active not recruiting
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03168737 2026-04-15

18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
25 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms

NCT01567800 2026-03-06

Prostate Hypoxia FAZA

University Health Network, Toronto

Phase NA Completed
18 enrolled
Genitourinary

Prostatic Neoplasms

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting
70 enrolled
Sarcoma

Hypoxia, Sarcoma

NCT04395469 2026-03-05

FAZA PET/MRI Pancreas

University Health Network, Toronto

Phase NA Active not recruiting
20 enrolled

Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡